Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis

Neurology. 2018 Oct 2;91(14):e1365-e1367. doi: 10.1212/WNL.0000000000006278.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents, Immunological / adverse effects*
  • Antineoplastic Agents, Immunological / therapeutic use
  • Humans
  • Male
  • Melanoma / therapy
  • Myasthenia Gravis / etiology*
  • Myasthenia Gravis / therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab